← All trials
NCT07297914
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2026
- Primary completion
- Nov 30, 2032
- Completion date
- Dec 1, 2032
- First posted
- Dec 22, 2025
- Last posted
- Dec 22, 2025
- Enrollment
- 1000
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bambino Gesù Hospital and Research InstituteLead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.